DIAKHOMBA DIABY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family PARIS, TX NPI 1477063006

General Payments — all program years on this page

$2,598.71

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 225
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $312.10 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $312.1019

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $603.6843
2022 $837.1188
2023 $845.8275
2024 $312.1019

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100458852 Novo Nordisk Inc $13.07 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100567748 Novo Nordisk Inc $13.61 04/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100610728 Novo Nordisk Inc $16.21 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104430819 AstraZeneca Pharmaceuticals LP $18.25 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115573625 Amgen Inc. $17.75 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116284654 GlaxoSmithKline, LLC. $14.02 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116625082 GlaxoSmithKline, LLC. $13.40 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135570583 Lilly USA, LLC $18.05 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136258093 SCILEX PHARMACEUTICALS INC. $15.47 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136265285 SCILEX PHARMACEUTICALS INC. $20.16 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139483304 Astellas Pharma US Inc $16.84 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139548559 Astellas Pharma US Inc $18.51 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141856474 Merck Sharp & Dohme LLC $13.88 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147310308 Mylan Specialty L.P. $15.22 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151160637 Phathom Pharmaceuticals, Inc. $14.05 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151160639 Phathom Pharmaceuticals, Inc. $20.05 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153357961 Dexcom, Inc. $18.06 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153357963 Dexcom, Inc. $19.02 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153578371 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.48 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.